Evidence map›Paper›PMID 40808718›Full record

ArticleBiochemistry and biophysics reports2025

Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III.

Sumit Thakur, Balvinder Singh, Ranvir Singh

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sumit ThakurDepartment cum National Centre of Human Genome Studies and Research, Panjab University, Chandigarh, India.
Balvinder SinghBioinformatics Center, Institute of Microbial Technology, Council of Scientific and Industrial Research, Chandigarh, India.
Ranvir SinghDepartment cum National Centre of Human Genome Studies and Research, Panjab University, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apolipoprotein E (Apo E) is involved in lipid metabolism and plays a crucial role in maintaining the balance of lipoprotein interactions within the body. Mutations in the Apo E protein have been associated with Hyperlipoproteinemia type III, which is characterized by abnormal lipid accumulation in the body. This work explores the structural and functional consequences of seven missense mutations (R154C, R154S, R160C, R163C, R163H, K164E, and K164Q) of Apo E protein associated with Hyperlipoproteinemia type III. Through computational methods such as homology modelling, pathogenicity prediction, Molecular docking and Molecular dynamics, we have investigated the impact of single-point mutations on protein structure, stability, and dynamics. Molecular dynamics simulation studies of wild type Apo E and modelled mutants provided insights into the conformational changes and flexibility of Apo E mutants, giving insights into mechanistic aspect of the influence of mutations on the receptor binding domain and protein structure. The results demonstrate that most of the studied mutations disrupt critical stabilizing interactions and alter domain flexibility thus destabilizing the protein structure and function affecting its interaction with Low-Density Lipoprotein receptor 1 (LDLR1). These molecular insights into how the mutations affect Apo E's conformation and its interaction with the LDL receptor 1 (LDLR1) will help to contribute to a deeper understanding of the pathogenesis of Hyperlipoproteinemia type III.

Indexed as

Apo EHomology modellingHyperlipoproteinemia type IIIMolecular dynamics

Identifiers

PMID40808718
PMCPMC12344191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.